Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Acute hepatic failure? 385 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 385 reports of Acute hepatic failure have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.5% of all adverse event reports for DOXORUBICIN.

385
Reports of Acute hepatic failure with DOXORUBICIN
0.5%
of all DOXORUBICIN reports
262
Deaths
172
Hospitalizations

How Dangerous Is Acute hepatic failure From DOXORUBICIN?

Of the 385 reports, 262 (68.1%) resulted in death, 172 (44.7%) required hospitalization, and 31 (8.1%) were considered life-threatening.

Is Acute hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 385 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Acute hepatic failure?

ACETAMINOPHEN (3,141) PREDNISONE (439) IBUPROFEN (412) RITUXIMAB (412) CYCLOPHOSPHAMIDE (411) VINCRISTINE (346) PREDNISOLONE (301) METHOTREXATE (285) DEXAMETHASONE (249) RIFAMPIN (210)

Which DOXORUBICIN Alternatives Have Lower Acute hepatic failure Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Acute hepatic failure Reports All Drugs Causing Acute hepatic failure DOXORUBICIN Demographics